MedPath

A clinical trial to study the effects of adapalene, benzoyl peroxide, and benzoyl peroxide-clindamycin combination in patients having pimples.

Phase 4
Conditions
Health Condition 1: null- Mild to Moderate Acne vulgaris
Registration Number
CTRI/2012/11/003127
Lead Sponsor
Peoples college of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
150
Inclusion Criteria

1. Healthy males, and non-pregnant females, aged 12-30 years with a clinical diagnosis of mild-moderate acne vulgaris.

2. Presence of Non-inflammatory lesions (comedones).

3. Presence of mild to moderate inflammatory lesions like papules and pustules (Grades 1 and 2).

Exclusion Criteria

1. Acne patients with ages below 12years, or above 30 years.

2. Pregnant and nursing females.

3. Presence of severe inflammatory lesions of acne like nodulo-cystic lesions (Grades 3 and 4).

4. Presence of any other skin condition that would interfere with the diagnosis and assessment of acne vulgaris, (eg-on the face-rosaceae, dermatitis).

5. Excessive facial hair (eg-beard) that would interfere with diagnosis or assessment of acne vulgaris.

6. History of hypersensitivity or allergy to these drugs.

7. Use of any other drug for the treatment of acne vulgaris within 2 months.

8. Patients on hormonal treatment.

9. Patient on drugs causing acne as a side effect.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Acne severity index <br/ ><br>Total acne lesion countTimepoint: Acne severity index and <br/ ><br>Total acne lesion count will be assessed after 2 4 6 8 10 12 weeks.
Secondary Outcome Measures
NameTimeMethod
Acne severity index <br/ ><br>Total acne lesion countTimepoint: 12 weeks
© Copyright 2025. All Rights Reserved by MedPath